Innoviva, Inc.
INVA
$20.86
$0.281.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 34.51% | 45.53% | 80.82% | 63.34% | 61.38% |
| Total Other Revenue | -0.52% | -0.26% | 0.30% | 1.21% | 9.59% |
| Total Revenue | 10.14% | 12.02% | 18.70% | 15.54% | 21.46% |
| Cost of Revenue | 13.47% | -10.21% | -34.07% | -49.64% | -4.15% |
| Gross Profit | 9.36% | 17.71% | 37.01% | 44.38% | 29.60% |
| SG&A Expenses | 1.73% | -1.43% | 3.59% | 17.81% | 31.71% |
| Depreciation & Amortization | 0.97% | 0.55% | 6.22% | 18.90% | 33.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 23.77% | 6.68% | -0.84% | -2.82% | -0.36% |
| Operating Income | -3.53% | 18.39% | 48.01% | 43.95% | 55.66% |
| Income Before Tax | 111.81% | -57.15% | -123.39% | -80.74% | 8.34% |
| Income Tax Expenses | 213.59% | 255.20% | -19.73% | -2.64% | -49.25% |
| Earnings from Continuing Operations | 97.15% | -73.42% | -132.93% | -86.98% | 29.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 97.15% | -73.42% | -132.93% | -86.98% | 29.50% |
| EBIT | -3.53% | 18.39% | 48.01% | 43.95% | 55.66% |
| EBITDA | -2.96% | 15.76% | 41.11% | 40.14% | 52.46% |
| EPS Basic | 88.04% | -72.73% | -133.73% | -86.70% | 23.55% |
| Normalized Basic EPS | 0.37% | 26.04% | 58.76% | 55.18% | 72.92% |
| EPS Diluted | 102.46% | -79.99% | -144.74% | -90.46% | 55.69% |
| Normalized Diluted EPS | -7.43% | 29.12% | 84.31% | 69.91% | 71.95% |
| Average Basic Shares Outstanding | 2.09% | -1.42% | -2.63% | -4.16% | -5.88% |
| Average Diluted Shares Outstanding | 7.23% | -7.51% | -15.19% | -9.87% | -5.17% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |